Global Microcrystalline Cellulose as Pharmaceutical Excipient Market Growth 2025-2031
Description
The global Microcrystalline Cellulose as Pharmaceutical Excipient market size is predicted to grow from US$ 794 million in 2025 to US$ 1232 million in 2031; it is expected to grow at a CAGR of 7.6% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Microcrystalline cellulose (MCC) is an odorless, tasteless, porous white powder derived from wood pulp or refined cotton.
MCC is commonly used as a binder in tablet formulations, helping to hold the active pharmaceutical ingredient (API) and other excipients together to form a coherent tablet. Additionally, it serves as a disintegrant, promoting the rapid breakup of tablets in the gastrointestinal tract for effective drug release.
Microcrystalline cellulose is derived from natural cellulose sources, making it inert and biocompatible. Its safety profile and compatibility with various APIs contribute to its widespread use in pharmaceutical formulations.
LP Information, Inc. (LPI) ' newest research report, the “Microcrystalline Cellulose as Pharmaceutical Excipient Industry Forecast” looks at past sales and reviews total world Microcrystalline Cellulose as Pharmaceutical Excipient sales in 2024, providing a comprehensive analysis by region and market sector of projected Microcrystalline Cellulose as Pharmaceutical Excipient sales for 2025 through 2031. With Microcrystalline Cellulose as Pharmaceutical Excipient sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Microcrystalline Cellulose as Pharmaceutical Excipient industry.
This Insight Report provides a comprehensive analysis of the global Microcrystalline Cellulose as Pharmaceutical Excipient landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Microcrystalline Cellulose as Pharmaceutical Excipient portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Microcrystalline Cellulose as Pharmaceutical Excipient market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microcrystalline Cellulose as Pharmaceutical Excipient and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microcrystalline Cellulose as Pharmaceutical Excipient.
This report presents a comprehensive overview, market shares, and growth opportunities of Microcrystalline Cellulose as Pharmaceutical Excipient market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Wood Pulp Based
Refined Cotton Based
Segmentation by Application:
Tablet
Capsule
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
DuPont
JRS
Mingtai
Asahi Kasei
Accent Microcell
Sigachi
Wei Ming Pharmaceutical
Roquette
Anhui Sunhere Pharmaceutical
Linghu Xinwang Chemical
Shandong Guangda
Huzhou Zhanwang Pharmaceutical
Jining Six Best Excipients
Aoda Pharmaceutical
QuFuShi Medical
Ahua Pharmaceutical
Qufu Tianli
Xinda biotchnology
Rutocel
Key Questions Addressed in this Report
What is the 10-year outlook for the global Microcrystalline Cellulose as Pharmaceutical Excipient market?
What factors are driving Microcrystalline Cellulose as Pharmaceutical Excipient market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Microcrystalline Cellulose as Pharmaceutical Excipient market opportunities vary by end market size?
How does Microcrystalline Cellulose as Pharmaceutical Excipient break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Microcrystalline cellulose (MCC) is an odorless, tasteless, porous white powder derived from wood pulp or refined cotton.
MCC is commonly used as a binder in tablet formulations, helping to hold the active pharmaceutical ingredient (API) and other excipients together to form a coherent tablet. Additionally, it serves as a disintegrant, promoting the rapid breakup of tablets in the gastrointestinal tract for effective drug release.
Microcrystalline cellulose is derived from natural cellulose sources, making it inert and biocompatible. Its safety profile and compatibility with various APIs contribute to its widespread use in pharmaceutical formulations.
LP Information, Inc. (LPI) ' newest research report, the “Microcrystalline Cellulose as Pharmaceutical Excipient Industry Forecast” looks at past sales and reviews total world Microcrystalline Cellulose as Pharmaceutical Excipient sales in 2024, providing a comprehensive analysis by region and market sector of projected Microcrystalline Cellulose as Pharmaceutical Excipient sales for 2025 through 2031. With Microcrystalline Cellulose as Pharmaceutical Excipient sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Microcrystalline Cellulose as Pharmaceutical Excipient industry.
This Insight Report provides a comprehensive analysis of the global Microcrystalline Cellulose as Pharmaceutical Excipient landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Microcrystalline Cellulose as Pharmaceutical Excipient portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Microcrystalline Cellulose as Pharmaceutical Excipient market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Microcrystalline Cellulose as Pharmaceutical Excipient and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Microcrystalline Cellulose as Pharmaceutical Excipient.
This report presents a comprehensive overview, market shares, and growth opportunities of Microcrystalline Cellulose as Pharmaceutical Excipient market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Wood Pulp Based
Refined Cotton Based
Segmentation by Application:
Tablet
Capsule
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
DuPont
JRS
Mingtai
Asahi Kasei
Accent Microcell
Sigachi
Wei Ming Pharmaceutical
Roquette
Anhui Sunhere Pharmaceutical
Linghu Xinwang Chemical
Shandong Guangda
Huzhou Zhanwang Pharmaceutical
Jining Six Best Excipients
Aoda Pharmaceutical
QuFuShi Medical
Ahua Pharmaceutical
Qufu Tianli
Xinda biotchnology
Rutocel
Key Questions Addressed in this Report
What is the 10-year outlook for the global Microcrystalline Cellulose as Pharmaceutical Excipient market?
What factors are driving Microcrystalline Cellulose as Pharmaceutical Excipient market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Microcrystalline Cellulose as Pharmaceutical Excipient market opportunities vary by end market size?
How does Microcrystalline Cellulose as Pharmaceutical Excipient break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
142 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Microcrystalline Cellulose as Pharmaceutical Excipient by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Microcrystalline Cellulose as Pharmaceutical Excipient by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
